Richard Giltner United Therapeutics Corp (UTHR) insider trading activity

Richard Giltner is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 17,420 shares of UTHR, which is worth approximately $6.26 Million. The most recent transaction as insider was on Nov 05, 2024, when has been sold 10,000 shares (Common Stock) at a price of $381.94 per share, resulting in proceeds of $3,819,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.4K

0% 3M change

11.52% 12M change

Total Value Held $6.26 Million

Richard Giltner Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 05 2024	SELL Open market or private sale	$3,819,400 $381.94 p/Share	10,000 Reduced 36.47%	17,420 Common Stock
Nov 05 2024	BUY Exercise of conversion of derivative security	$1,754,300 $175.43 p/Share	10,000 Added 26.72%	27,420 Common Stock
Jul 13 2024	BUY Exercise of conversion of derivative security	-	1,800 Added 9.37%	17,420 Common Stock
Mar 06 2024	SELL Sale (or disposition) back to the issuer	$2,369,700 $236.97 p/Share	10,000 Reduced 39.03%	15,620 Common Stock
Mar 06 2024	BUY Exercise of conversion of derivative security	$880,300 $88.03 p/Share	10,000 Added 28.07%	25,620 Common Stock
Dec 01 2023	SELL Sale (or disposition) back to the issuer	$1,203,650 $240.73 p/Share	5,000 Reduced 24.25%	15,620 Common Stock
Dec 01 2023	BUY Exercise of conversion of derivative security	$440,150 $88.03 p/Share	5,000 Added 19.52%	20,620 Common Stock
Jul 07 2023	BUY Exercise of conversion of derivative security	-	1,750 Added 10.07%	15,620 Common Stock
May 22 2023	SELL Sale (or disposition) back to the issuer	$1,092,950 $218.59 p/Share	5,000 Reduced 26.5%	13,870 Common Stock
May 22 2023	BUY Exercise of conversion of derivative security	$319,500 $63.9 p/Share	5,000 Added 20.95%	18,870 Common Stock
Nov 16 2022	SELL Sale (or disposition) back to the issuer	$2,610,500 $261.05 p/Share	10,000 Reduced 41.89%	13,870 Common Stock
Nov 16 2022	BUY Exercise of conversion of derivative security	$639,000 $63.9 p/Share	10,000 Added 29.52%	23,870 Common Stock
Jul 08 2022	BUY Exercise of conversion of derivative security	-	2,160 Added 13.47%	13,870 Common
Jun 26 2021	BUY Exercise of conversion of derivative security	-	3,360 Added 22.3%	11,710 Common Stock
Jan 06 2021	SELL Sale (or disposition) back to the issuer	$1,635,100 $163.51 p/Share	10,000 Reduced 54.5%	8,350 Common Stock
Jan 06 2021	BUY Exercise of conversion of derivative security	$481,100 $48.11 p/Share	10,000 Added 35.27%	18,350 Common Stock
Jan 05 2021	SELL Sale (or disposition) back to the issuer	$783,850 $156.77 p/Share	5,000 Reduced 37.45%	8,350 Common Stock
Jan 05 2021	BUY Exercise of conversion of derivative security	$240,550 $48.11 p/Share	5,000 Added 27.25%	13,350 Common Stock
Jan 04 2021	SELL Sale (or disposition) back to the issuer	$769,700 $153.94 p/Share	5,000 Reduced 37.45%	8,350 Common Stock
Jan 04 2021	BUY Exercise of conversion of derivative security	$273,850 $54.77 p/Share	5,000 Added 27.25%	13,350 Common Stock
Dec 17 2020	SELL Sale (or disposition) back to the issuer	$742,200 $148.44 p/Share	5,000 Reduced 37.45%	8,350 Common Stock
Dec 17 2020	BUY Exercise of conversion of derivative security	$273,850 $54.77 p/Share	5,000 Added 27.25%	13,350 Common Stock
Nov 04 2020	SELL Sale (or disposition) back to the issuer	$697,350 $139.47 p/Share	5,000 Reduced 37.45%	8,350 Common Stock
Nov 04 2020	BUY Exercise of conversion of derivative security	$273,850 $54.77 p/Share	5,000 Added 27.25%	13,350 Common Stock

Richard Giltner

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account